GB202211273D0 - Compounds for use in the treatment of diseases and conditions associated with inflammation - Google Patents

Compounds for use in the treatment of diseases and conditions associated with inflammation

Info

Publication number
GB202211273D0
GB202211273D0 GBGB2211273.4A GB202211273A GB202211273D0 GB 202211273 D0 GB202211273 D0 GB 202211273D0 GB 202211273 A GB202211273 A GB 202211273A GB 202211273 D0 GB202211273 D0 GB 202211273D0
Authority
GB
United Kingdom
Prior art keywords
inflammation
diseases
compounds
treatment
conditions associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2211273.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ontrack Therapeutics Ltd
Original Assignee
Ontrack Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ontrack Therapeutics Ltd filed Critical Ontrack Therapeutics Ltd
Publication of GB202211273D0 publication Critical patent/GB202211273D0/en
Priority to GB2302120.7A priority Critical patent/GB2619119A/en
Priority to PCT/GB2023/051355 priority patent/WO2023227881A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB2211273.4A 2022-05-24 2022-08-02 Compounds for use in the treatment of diseases and conditions associated with inflammation Ceased GB202211273D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB2302120.7A GB2619119A (en) 2022-05-24 2023-02-14 Compounds for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
PCT/GB2023/051355 WO2023227881A1 (en) 2022-05-24 2023-05-24 Compounds for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2207556.8A GB202207556D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Publications (1)

Publication Number Publication Date
GB202211273D0 true GB202211273D0 (en) 2022-09-14

Family

ID=82220581

Family Applications (3)

Application Number Title Priority Date Filing Date
GBGB2207556.8A Ceased GB202207556D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
GBGB2211273.4A Ceased GB202211273D0 (en) 2022-05-24 2022-08-02 Compounds for use in the treatment of diseases and conditions associated with inflammation
GB2302120.7A Pending GB2619119A (en) 2022-05-24 2023-02-14 Compounds for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB2207556.8A Ceased GB202207556D0 (en) 2022-05-24 2022-05-24 Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2302120.7A Pending GB2619119A (en) 2022-05-24 2023-02-14 Compounds for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction

Country Status (1)

Country Link
GB (3) GB202207556D0 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4344743A2 (en) * 2018-08-07 2024-04-03 Emory University Heterocyclic flavone derivatives, compositions, and methods related thereto

Also Published As

Publication number Publication date
GB2619119A (en) 2023-11-29
GB202302120D0 (en) 2023-03-29
GB202207556D0 (en) 2022-07-06

Similar Documents

Publication Publication Date Title
IL289167A (en) 2h-indazole derivatives and their use in the treatment of disease
IL284125A (en) Quinoline derivatives for use in the treatment of inflammation diseases
EP3969125A4 (en) Use of anti-fcrn antibodies in the treatment of pemphighus and pemphigoid diseases
EP4149482A4 (en) 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation
IL288882A (en) Mixture of plant extracts for use in the prevention and/or treatment of chronic inflammatory bowel diseases
IL272253A (en) Compositions and methods for treatment of inflammatory conditions and diseases of the skin
EP4054713A4 (en) Compositions and methods for treatment or prevention of skin diseases and disorders with lekti
IL289289A (en) Polyaromatic urea derivatives and their use in the treatment of muscle diseases
PT3937948T (en) Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases
GB202211273D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation
EP3766503A4 (en) Application of microrna-210 inhibitor in the preparation of drugs for treating inflammatory skin diseases
GB202217453D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
GB202208255D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
GB202208256D0 (en) Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity
IL282718A (en) Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity
IL290192A (en) Nitenin analogue compounds and their use in the treatment of chronic and acute pain
EP4017496A4 (en) Formulations for use in the prevention and/or treatment of peripheral neuropathy and its associated diseases
GB202304262D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
GB202207559D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders
GB202211274D0 (en) Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction
GB202217454D0 (en) Compounds for use in the treatment of diseases and conditions associated with anxiety and / or mood disorders
EP4046658A4 (en) Application of non-igf1r-binding substance in prevention and/or treatment of inflammatory diseases
GB2603379B (en) Avocatin B for the treatment of diseases and conditions
GB202202541D0 (en) Composition for use in the treatment and/or prevention of mycotoxic disease
GB202012967D0 (en) Compostions and methods relating to the treatment of diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)